Abstract:
A benzofuran compound represented by the general formula (I): (I) (wherein the symbols are as defined in the description) or a pharmaceutically acceptable salt thereof. The compound is highly effective in leucotriene inhibition, BLT2 antagonistic inhibition, BLT2 blocking, allergy prevention/treatments, asthma prevention/treatments, and inflammation prevention/treatments and is useful as a preventive/therapeutic agent for allergic diseases, diseases such as asthma and inflammation, and other diseases.
Abstract:
An oncogene therapeutic drug which contains a carrier cell having been infected with an oncolytic virus so as to treat a tumor cell with the virus within the living body. As the carrier cell, any of an A549 cell, a 293 cell, an SW626 cell and an HT-3 cell showing a potent antitumor effect is used. Because of using such a cell having a high antitumor effect both in vitro and in vivo as the carrier cell, an enhanced antitumor effect can be established compared with conventional carrier cells.
Abstract:
A secondary cell charger and a secondary cell charging method for preventing undercharging or supercharging of a secondary cell and enabling reliable quick charging. After a predetermined charging applied voltage value Es above a full-charge balanced voltage value Eeq is applied to a secondary cell (1) for a predetermined time, the applied voltage is changed to the full-charge balanced voltage value Eeq. The value i of the current flowing at this time is measured and compared with a predetermined charging end reference current value J. If the current value i is greater than the predetermined charging end reference current value J, the predetermined charging applied voltage value Es is applied to the secondary cell (1) again, and the flow is repeated. Whereas, if the current value i is less than the predetermined charging end reference current value J, the charging of the secondary cell (1) is stopped.
Abstract:
An oncogene therapeutic drug which comprises a combination of a virus for an immunological treatment to be administered for inducing a CTL reaction within the living body with a carrier cell having been infected with an oncolytic virus before administration so as to treat a tumor cell with the virus within the living body. As the carrier cell, use can be made of, for example, an A549 cell. As the virus for an immunological treatment, use can be made of, for example, a non-proliferative adenovirus having been inactivated by UV irradiation. As the oncolytic virus, use can be made of, for example, a proliferative adenovirus having a tumor-specific promoter.
Abstract:
A single crystal silicon carbide which has no crystallite grain boundary inside and contains micro−pipe defects in a density of 1/cm 2 or less, and preferably has a terrace having a width of 10 μm or more and a multi−molecular layer step having a three−molecular layer as the minimum unit; a method for producing the single crystal silicon carbide which comprises a high temperature liquid phase growth method using an extremely thin Si melt layer. The method is advantageous in that it does not require precise control of the temperature difference between the surface of a growing crystal and a polycrystalline raw material and that the addition of impurities can be controlled.
Abstract:
By focusing attention on SREBP-1 gene, the relationship between this gene and the degree of unsaturation in beef body fat is examined. As a result, it is found out that this gene occurs as an "L-type" gene having a longer fifth intron and an "S-type" gene having a fifth intron shorter by 84 bases than the above one and these genotypes relate to the degree of unsaturation in beef body fat. A method of evaluating the content of unsaturated fatty acids in beef body fat based on these SREBP-1 genotypes is applicable to the evaluation of beef taste, texture and so on and, therefore, is industrially useful.
Abstract:
Paying attention to stearoyl-CoA desaturase gene and examining the relationship between this gene and the degree of unsaturation in beef body fat, a plural number of single nucleotide polymorphisms (SNP’s) are found out in this gene. It is also found out that the degree of unsaturation in beef body fat relates to the genotype of the gene classified based on these SNP’s. A method of judging the content of unsaturated fatty acids in beef body fat or milk fat based on the stearoyl-CoA desaturase genotype is an industrially useful method which is applicable to the judgment of beef taste, texture and so on.
Abstract:
Una placa negativa híbrida para una batería de almacenamiento de ácido-plomo, incluyendo una placa llena de material activo de electrodo negativo en cuya superficie se ha formado una capa de recubrimiento de una mezcla de carbono incluyendo un material de carbono para asegurar la conductividad, un carbono activado para asegurar la capacidad de condensador y/o la capacidad de pseudocondensador, y al menos un ligante, donde el carbono activado es carbono activado modificado con un grupo funcional, caracterizada porque el carbono activado modificado con un grupo funcional contiene un componente volátil en una cantidad de 3 a 30% en peso.
Abstract:
A method for evaluating the amount of the unsaturated fatty acid content in beef fat on the basis of a genotype of bovine stearoyl-CoA desaturase to evaluate whether it is cattle from which good quality beef with good taste and texture can be produced is described. The method comprises determining the single nuclear polymorphisms (SNP) found in the gene of SEQ ID NO:1 present at position 878 and at positions 702, 762, 878, 1905, 3143, 3351, 3537 and/or 4736.